Advertisement
Skip to Content

Janus Henderson Global Life Sciences C JFNCX Fund Analysis

| Quantitative rating as of | See Janus Henderson Investment Hub

Morningstar’s Analysis JFNCX

Will JFNCX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Summary

|

Janus Henderson Global Life Sciences C's Average People and Parent ratings limit this strategy to a Morningstar Quantitative Rating of Neutral. Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Unlock our full analysis with Morningstar Investor